Puneet Souda
Stock Analyst at Leerink Partners
(1.60)
# 3,178
Out of 4,873 analysts
213
Total ratings
47.4%
Success rate
-1.37%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $6.20 | +29.03% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $7.18 | +25.35% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $64.27 | +16.70% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $5.12 | +310.16% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $6.78 | -41.00% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $26.45 | +51.23% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $164.16 | -8.63% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $350.01 | +7.14% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.16 | +39.66% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $410.65 | +53.42% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $19.47 | +79.76% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $118.62 | +22.24% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $201.00 | +49.25% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $93.23 | +168.15% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $51.89 | +111.99% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $51.92 | +44.45% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $124.02 | +61.26% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $3.80 | +373.68% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.66 | +262.54% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $36.99 | -18.90% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $40.93 | +112.56% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $49.90 | +180.56% | 5 | Feb 24, 2022 |
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $6.20
Upside: +29.03%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $7.18
Upside: +25.35%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $64.27
Upside: +16.70%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $5.12
Upside: +310.16%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $6.78
Upside: -41.00%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $26.45
Upside: +51.23%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $164.16
Upside: -8.63%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $350.01
Upside: +7.14%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.16
Upside: +39.66%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $410.65
Upside: +53.42%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $19.47
Upside: +79.76%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $118.62
Upside: +22.24%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $201.00
Upside: +49.25%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $93.23
Upside: +168.15%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $51.89
Upside: +111.99%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $51.92
Upside: +44.45%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $124.02
Upside: +61.26%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $3.80
Upside: +373.68%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.66
Upside: +262.54%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $36.99
Upside: -18.90%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $40.93
Upside: +112.56%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $49.90
Upside: +180.56%